Time to metastatic relapse and breast cancer cells dissemination in bone marrow at metastatic relapse

被引:12
作者
Bidard, Francois-Clement [1 ]
Vincent-Salomon, Anne [2 ]
Sigal-Zafrani, Brigitte [2 ]
Rodrigues, Manuel [1 ]
Dieras, Veronique [1 ]
Mignot, Laurent [1 ]
Sastre-Garau, Xavier [2 ]
Poupon, Marie-France [3 ]
Pierga, Jean-Yves [1 ,4 ]
机构
[1] Inst Curie, Dept Med Oncol, F-75005 Paris, France
[2] Inst Curie, Dept Pathol, F-75005 Paris, France
[3] Inst Curie, Dept Translat Res, F-75005 Paris, France
[4] Univ Paris 05, Paris, France
关键词
Disseminated tumor cells; Bone marrow; Micrometastasis; Metastasis; Breast cancer;
D O I
10.1007/s10585-008-9203-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer dissemination can be monitored in patients by detecting circulating and/or disseminated tumor cells. However, bone marrow disseminated tumor cells (BM DTC) may undergo a dormancy during several years before growing (or not) into clinically detectable metastases. We therefore hypothesized that breast cancers which have formed BM DTC in the course of their metastatic growth might exhibit a longer interval before metastatic relapse. We examined the association of DTC detection (cytokeratin 8, 18 or 19 positive epithelial cells with cancerous morphological features), at metastatic relapse, with the metastasis-free interval in breast cancer patients. In the 110 metastatic patients studied, 42% (n = 64/110) were classified as BM DTC-negative. These patients had a significantly shorter metastasis-free interval than BM DTC-positive patients (P = 0.02). In multivariate logistic regression analysis, the metastasis-free interval was an independent predictor of DTC detection (P = 0.02), together with bone metastasis (P = 0.0003) and low tumor grade (grade I or II, P = 0.05). We finally suggest that a faster metastatic process might skip in some patients the BM DTC-associated dormancy step. Dissemination of DTC in other host organ and/or epithelial-mesenchymal transition from cytokeratin-positive to cytokeratin-negative DTC may explain this observation.
引用
收藏
页码:871 / 875
页数:5
相关论文
共 22 条
[11]   American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer [J].
Harris, Lyndsay ;
Fritsche, Herbert ;
Mennel, Robert ;
Norton, Larry ;
Ravdin, Peter ;
Taube, Sheila ;
Somerfield, Mark R. ;
Hayes, Daniel F. ;
Bast, Robert C., Jr. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (33) :5287-5312
[12]   The epithelial-mesenchymal transition generates cells with properties of stem cells [J].
Mani, Sendurai A. ;
Guo, Wenjun ;
Liao, Mai-Jing ;
Eaton, Elinor Ng. ;
Ayyanan, Ayyakkannu ;
Zhou, Alicia Y. ;
Brooks, Mary ;
Reinhard, Ferenc ;
Zhang, Cheng Cheng ;
Shipitsin, Michail ;
Campbell, Lauren L. ;
Polyak, Kornelia ;
Brisken, Cathrin ;
Yang, Jing ;
Weinberg, Robert A. .
CELL, 2008, 133 (04) :704-715
[13]   Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer [J].
Naume, Bjorn ;
Zhao, Xi ;
Synnestvedt, Marit ;
Borgen, Elin ;
Russnes, Hege Giercksky ;
Lingjaerde, Ole Christian ;
Stromberg, Maria ;
Wiedswang, Gro ;
Kvalheim, Gunnar ;
Karesen, Rolf ;
Nesland, Jahn M. ;
Borresen-Dale, Anne-Lise ;
Sorlie, Therese .
MOLECULAR ONCOLOGY, 2007, 1 (02) :160-171
[14]   Variation of circulating tumor cell levels during treatment of metastatic breast cancer:: prognostic and therapeutic implications [J].
Nole, F. ;
Munzone, E. ;
Zorzino, L. ;
Minchella, I. ;
Salvatici, M. ;
Botteri, E. ;
Medici, M. ;
Verri, E. ;
Adamoli, L. ;
Rotmensz, N. ;
Goldhirsch, A. ;
Sandri, M. T. .
ANNALS OF ONCOLOGY, 2008, 19 (05) :891-897
[15]   Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse [J].
Pachmann, Katharina ;
Camara, Oumar ;
Kavallaris, Andreas ;
Krauspe, Sabine ;
Malarski, Nele ;
Gajda, Mieczyslaw ;
Kroll, Torsten ;
Joerke, Cornelia ;
Hammer, Ulrike ;
Altendorf-Hofmann, Annelore ;
Rabenstein, Carola ;
Pachmann, Ulrich ;
Runnebaum, Ingo ;
Hoeffken, Klaus .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (08) :1208-1215
[16]   Circulating Tumor Cell Detection Predicts Early Metastatic Relapse After Neoadjuvant Chemotherapy in Large Operable and Locally Advanced Breast Cancer in a Phase II Randomized Trial [J].
Pierga, Jean-Yves ;
Bidard, Francois-Clement ;
Mathiot, Claire ;
Brain, Etienne ;
Delaloge, Suzette ;
Giachetti, Sylvie ;
de Cremoux, Patricia ;
Salmon, Remy ;
Vincent-Salomon, Anne ;
Marty, Michel .
CLINICAL CANCER RESEARCH, 2008, 14 (21) :7004-7010
[17]   Clinical significance of immunocytochemical detection of tumor cells using digital microscopy in peripheral blood and bone marrow of breast cancer patients [J].
Pierga, JY ;
Bonneton, C ;
Vincent-Salomon, A ;
de Cremoux, P ;
Nos, C ;
Blin, N ;
Pouillart, P ;
Thiery, JP ;
Magdelénat, H .
CLINICAL CANCER RESEARCH, 2004, 10 (04) :1392-1400
[18]   Tumor metastasis: mechanistic insights and clinical challenges [J].
Steeg, Patricia S. .
NATURE MEDICINE, 2006, 12 (08) :895-904
[19]   Bone marrow micrometastasis in breast cancer: review of detection methods, prognostic impact and biological issues [J].
Vincent-Salomon, A. ;
Bidard, F. C. ;
Pierga, J. Y. .
JOURNAL OF CLINICAL PATHOLOGY, 2008, 61 (05) :570-576
[20]   Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer [J].
Wiedswang, G ;
Borgen, E ;
Karesen, R ;
Kvalheim, G ;
Nesland, JM ;
Schlichting, HQE ;
Sauer, T ;
Janbu, J ;
Harbitz, T ;
Naume, B .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (18) :3469-3478